Conduit Pharmaceuticals Inc. has announced the filing of four new patent applications related to its key assets AZD1656 and AZD5658, marking its first filings for AZD5658. These patents, which include ...
Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658 Patents derived from AI-led analysis conducted in partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback